- Home
- TNGX vs JFIN Comparison
TNGX vs JFIN Comparison
Compare TNGX & JFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- JFIN
- Stock Information
- Founded
- TNGX 2014
- JFIN 2011
- Country
- TNGX United States
- JFIN China
- Employees
- TNGX N/A
- JFIN N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- JFIN Finance: Consumer Services
- Sector
- TNGX Health Care
- JFIN Finance
- Exchange
- TNGX Nasdaq
- JFIN Nasdaq
- Market Cap
- TNGX 413.6M
- JFIN 352.7M
- IPO Year
- TNGX N/A
- JFIN 2019
- Fundamental
- Price
- TNGX $3.92
- JFIN $5.87
- Analyst Decision
- TNGX Strong Buy
- JFIN
- Analyst Count
- TNGX 8
- JFIN 0
- Target Price
- TNGX $13.14
- JFIN N/A
- AVG Volume (30 Days)
- TNGX 3.5M
- JFIN 56.4K
- Earning Date
- TNGX 11-06-2024
- JFIN 11-20-2024
- Dividend Yield
- TNGX N/A
- JFIN 15.33%
- EPS Growth
- TNGX N/A
- JFIN N/A
- EPS
- TNGX N/A
- JFIN N/A
- Revenue
- TNGX $43,383,000.00
- JFIN $854,955,021.00
- Revenue This Year
- TNGX $25.55
- JFIN N/A
- Revenue Next Year
- TNGX N/A
- JFIN N/A
- P/E Ratio
- TNGX N/A
- JFIN $1.90
- Revenue Growth
- TNGX 15.67
- JFIN 21.87
- 52 Week Low
- TNGX $2.70
- JFIN $4.00
- 52 Week High
- TNGX $13.01
- JFIN $8.58
- Technical
- Relative Strength Index (RSI)
- TNGX 39.26
- JFIN 35.84
- Support Level
- TNGX $3.54
- JFIN $5.18
- Resistance Level
- TNGX $4.22
- JFIN $6.85
- Average True Range (ATR)
- TNGX 0.53
- JFIN 0.35
- MACD
- TNGX 0.13
- JFIN -0.09
- Stochastic Oscillator
- TNGX 48.61
- JFIN 41.32
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About JFIN Jiayin Group Inc.
Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital + technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.